Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

13 Jan 2017 Evaluate

Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on January 24, 2017, to consider, approving and taking on record Unaudited (Consolidated & Standalone) Financial Results of the Company for the third quarter ended December 31, 2016 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1876.70
Dr. Reddys Labs. 1373.60
Cipla 1392.20
Lupin 1966.20
Zydus Lifesciences 1202.50
View more..